Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

FDA Approves Sickle Cell Drug

The Food and Drug Administration today approved a new drug that reduces the tendency for blood cells in people with sickle cell disease to stick together and block blood vessels. . . . → Read More: FDA Approves Sickle Cell Drug

Little Health Impact Found from Engineered Mosquitoes

An assessment by Dutch health authorities concludes mosquitoes genetically engineered to produce offspring that die before adulthood pose few health or environmental risks to humans. . . . → Read More: Little Health Impact Found from Engineered Mosquitoes

Nerve Stimulation Approved for Children’s Epilepsy

The U.S. Food and Drug Administration approved use of vagus nerve stimulation to treat epilepsy in children who do not respond to drug therapy as young as 4 years old. . . . → Read More: Nerve Stimulation Approved for Children’s Epilepsy

FDA Approves Skin Infection Drug

The U.S. Food and Drug Administration approved a new drug that treats serious bacterial skin infections, including those often resistant to current antibiotics. . . . → Read More: FDA Approves Skin Infection Drug

FDA Developing Digital Device Certification Process

The U.S. Food and Drug Administration expects to unveil a new procedure for certifying digital medical devices that the agency says should speed their entry to the market. . . . → Read More: FDA Developing Digital Device Certification Process

Supreme Court Cuts Biosimilar Waiting Time

The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products. . . . → Read More: Supreme Court Cuts Biosimilar Waiting Time

Trial Begins of Freeze-Dried Blood Plasma

A clinical trial is underway testing the safety and practicality of using a person’s own freeze-dried blood plasma for transfusions, substituting for frozen or liquid plasma. . . . → Read More: Trial Begins of Freeze-Dried Blood Plasma

Trial to Test Spherical Nanotech Brain Cancer Drug

An early-stage clinical trial will soon begin testing spherically-shaped nanoscale particles to treat glioblastoma, an aggressive form of brain cancer. . . . → Read More: Trial to Test Spherical Nanotech Brain Cancer Drug

$2 Billion Biotech Licensing Deal Cancelled

A licensing deal with a potential value of more than $2 billion between two biotechnology companies for a new breast cancer drug was cancelled on Friday. . . . → Read More: $2 Billion Biotech Licensing Deal Cancelled

FDA Warns Cancer Fraud Product Providers

The Food and Drug Administration sent warning letters to 14 companies in the U.S. that the agency says are selling products fraudulently claiming to prevent, diagnose, treat, or cure cancer. . . . → Read More: FDA Warns Cancer Fraud Product Providers